• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用传统中药补中益气汤(TJ - 41:补中益气汤)从应激诱导的抑制中恢复抗肿瘤T细胞反应。

The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).

作者信息

Li T, Tamada K, Abe K, Tada H, Onoe Y, Tatsugami K, Harada M, Kubo C, Nomoto K

机构信息

Department of Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

出版信息

Immunopharmacology. 1999 Jun;43(1):11-21. doi: 10.1016/s0162-3109(99)00034-x.

DOI:10.1016/s0162-3109(99)00034-x
PMID:10437652
Abstract

We previously reported that restraint stress impairs the antitumor immune responses through its suppressive effect on the Th1-type cytokine production from CD4+ T cells. In this study, we investigated a potential of Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang) to restore stress-induced immunosuppression. The oral administration of TJ-41 was able to improve a decreased cellularity in the lymph node and spleen and to improve an inhibition of tumor-specific Th1-type cytokine production, both of which were induced by repeated restraint stress in tumor-bearing mice. The oral administration of TJ-41 also induced a partial recovery of the antitumor cytolytic activity in the stress-burdened tumor-bearing mice. More importantly, the growth of tumors in stress-burdened preimmunized mice was obviously inhibited by TJ-41, and resulted in tumor-free state in 75% of the mice. Regarding the mechanisms by which TJ-41 restored the antitumor responses in stress-burdened mice, we found that the serum levels of corticosterone and interleukin-12 were normalized by TJ-41. In addition, the expression of CD80 and CD86, which both decreased in the stress-burdened mice, was restored to the normal level by TJ-41. Taken together, our results indicate that the oral administration of TJ-41 is able to restore the antitumor T cell responses in stress-burdened tumor-bearing mice by normalizing the serum corticosterone, interleukin-12 and the expression of costimulatory molecules.

摘要

我们之前报道过,束缚应激通过抑制CD4+ T细胞产生Th1型细胞因子来损害抗肿瘤免疫反应。在本研究中,我们调查了补中益气汤(TJ-41)恢复应激诱导的免疫抑制的潜力。给荷瘤小鼠反复施加束缚应激会导致其淋巴结和脾脏细胞数量减少以及肿瘤特异性Th1型细胞因子产生受到抑制,而口服TJ-41能够改善这些情况。口服TJ-41还能使承受应激的荷瘤小鼠的抗肿瘤细胞溶解活性部分恢复。更重要的是,TJ-41明显抑制了承受应激的预免疫小鼠体内肿瘤的生长,使75%的小鼠达到无瘤状态。关于TJ-41恢复承受应激小鼠抗肿瘤反应的机制,我们发现TJ-41使皮质酮和白细胞介素-12的血清水平恢复正常。此外,承受应激的小鼠体内均降低的CD80和CD86的表达也通过TJ-41恢复到了正常水平。综上所述,我们的结果表明,口服TJ-41能够通过使血清皮质酮、白细胞介素-12以及共刺激分子的表达恢复正常,来恢复承受应激的荷瘤小鼠的抗肿瘤T细胞反应。

相似文献

1
The restoration of the antitumor T cell response from stress-induced suppression using a traditional Chinese herbal medicine Hochu-ekki-to (TJ-41:Bu-Zhong-Yi-Qi-Tang).使用传统中药补中益气汤(TJ - 41:补中益气汤)从应激诱导的抑制中恢复抗肿瘤T细胞反应。
Immunopharmacology. 1999 Jun;43(1):11-21. doi: 10.1016/s0162-3109(99)00034-x.
2
Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang).口服汉方药物补中益气汤(TJ-41)可增强对肿瘤发展的伴随免疫。
Immunopharmacol Immunotoxicol. 1995 Nov;17(4):687-703. doi: 10.3109/08923979509037189.
3
Development of the susceptibility to oral tolerance induction in infant mice administered a herbal drug, Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang).给予中药补中益气汤(Hochu-ekki-to)的幼鼠口服耐受诱导易感性的发展
Int Immunopharmacol. 2001 Feb;1(2):219-27. doi: 10.1016/s1567-5769(00)00022-9.
4
Protective effect of a traditional Japanese medicine, Bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to), on the restraint stress-induced susceptibility against Listeria monocytogenes.传统日本药物补中益气汤(日语名称:补中益气汤)对束缚应激诱导的单核细胞增生李斯特菌易感性的保护作用。
Immunopharmacology. 2000 Jun;48(1):35-42. doi: 10.1016/s0162-3109(00)00176-4.
5
Effect of a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: Hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice.中药补中益气汤(日语名称:补中益气汤)对小鼠抗单核细胞增生李斯特菌感染的保护作用。
Immunopharmacol Immunotoxicol. 1992;14(3):383-402. doi: 10.3109/08923979209005400.
6
Repeated restraint stress impairs the antitumor T cell response through its suppressive effect on Th1-type CD4+ T cells.反复的束缚应激通过对Th1型CD4+ T细胞的抑制作用损害抗肿瘤T细胞反应。
Anticancer Res. 1997 Nov-Dec;17(6D):4259-68.
7
Suppression of IgE production in mice treated with a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: hochu-ekki-to).用中药补中益气汤(日语名称:补中益气汤)治疗的小鼠中IgE产生的抑制作用
Immunopharmacology. 1997 Apr;36(1):79-85. doi: 10.1016/s0162-3109(96)00162-2.
8
Analysis of the restorative effect of Bu-zhong-yi-qi-tang in the spleen-qi deficiency rat model using (1)H-NMR-based metabonomics.基于(1)H-NMR 的代谢组学分析补中益气汤对脾气虚证大鼠模型的修复作用。
J Ethnopharmacol. 2014 Feb 3;151(2):912-20. doi: 10.1016/j.jep.2013.12.001. Epub 2013 Dec 12.
9
Kampo formula hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang, TJ-41) ameliorates muscle atrophy by modulating atrogenes and AMPK in vivo and in vitro.汉方药方剂独活寄生汤(补中益气汤,TJ-41)通过体内和体外调节抗肌萎缩基因和 AMPK 来改善肌肉萎缩。
BMC Complement Med Ther. 2022 Dec 28;22(1):341. doi: 10.1186/s12906-022-03812-w.
10
A screening strategy for bioactive components of Bu-Zhong-Yi-Qi-Tang regulating spleen-qi deficiency based on "endobiotics-targets-xenobiotics" association network.基于“内源性物质-靶点-外源性物质”关联网络的补中益气汤调节脾气虚证的生物活性成分筛选策略。
J Ethnopharmacol. 2023 Oct 5;314:116605. doi: 10.1016/j.jep.2023.116605. Epub 2023 May 11.

引用本文的文献

1
Therapeutic and immunomodulatory effects of Bojungikki-tang on cancer: a scoping review.博君济芪汤治疗癌症的疗效和免疫调节作用:范围综述。
BMC Cancer. 2024 Sep 20;24(1):1169. doi: 10.1186/s12885-024-12924-0.
2
Immune-Related Adverse Events due to Concomitant Use of Immune Checkpoint Inhibitors and Chinese Herbal Medicines: A Study Based on a Japanese Adverse Event Database.免疫检查点抑制剂与中草药联合使用所致免疫相关不良事件:基于日本不良事件数据库的研究。
Asian Pac J Cancer Prev. 2024 Jul 1;25(7):2291-2295. doi: 10.31557/APJCP.2024.25.7.2291.
3
Editorial: Local and traditional medicine in regulation of the cancer immune suppression microenvironment, Volume II.
社论:《局部与传统医学对癌症免疫抑制微环境的调节》第二卷
Front Pharmacol. 2023 May 12;14:1192478. doi: 10.3389/fphar.2023.1192478. eCollection 2023.
4
Safety and Efficacy of in Advanced NSCLC Patients Receiving Treatment with Immune Checkpoint Inhibitors: Protocol for a Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot Trial.在接受免疫检查点抑制剂治疗的晚期 NSCLC 患者中 的安全性和疗效:一项多中心、双盲、随机、安慰剂对照的初步试验方案。
Int J Environ Res Public Health. 2023 Mar 3;20(5):4507. doi: 10.3390/ijerph20054507.
5
Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice.补中益气汤通过调节MC38荷瘤小鼠的肿瘤微环境改善对PD-L1免疫疗法的反应。
Front Pharmacol. 2022 Jul 6;13:901563. doi: 10.3389/fphar.2022.901563. eCollection 2022.
6
Kampo Medicine Treatment for Advanced Pancreatic Cancer: A Case Series.汉方医学治疗晚期胰腺癌:病例系列
Front Nutr. 2021 Aug 12;8:702812. doi: 10.3389/fnut.2021.702812. eCollection 2021.
7
Developing Phytocompounds from Medicinal Plants as Immunomodulators.从药用植物中开发植物化合物作为免疫调节剂。
Adv Bot Res. 2012;62:197-272. doi: 10.1016/B978-0-12-394591-4.00004-0. Epub 2012 Jun 19.
8
Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.中医在癌症预防、治疗及癌症转移方面的应用
Oncol Lett. 2015 Sep;10(3):1240-1250. doi: 10.3892/ol.2015.3459. Epub 2015 Jul 6.
9
Bu-zhong-yi-qi pill alleviate the chemotherapy-related fatigue in 4 T1 murine breast cancer model.补中益气丸减轻4T1小鼠乳腺癌模型中与化疗相关的疲劳。
BMC Complement Altern Med. 2014 Dec 15;14:497. doi: 10.1186/1472-6882-14-497.
10
Changes of peripheral blood lymphocyte subtypes in patients with end stage cancer administered localized radiotherapy and bojungikki-tang.局部放疗和补中益气汤治疗晚期癌症患者外周血淋巴细胞亚群的变化。
Evid Based Complement Alternat Med. 2014;2014:207613. doi: 10.1155/2014/207613. Epub 2014 Feb 20.